Sugi Predict

Sugi Predict / Compounds / SCHEMBL5338446

SCHEMBL5338446

SCHEMBL5338446

CCCCS(=O)(=O)CCCCn1c(C)nc2c(N)nc(C)c(C)c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 2/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ CSNK2A2 P19784 1/20 0.34
▸ CSNK2B P67870 1/20 0.34
▸ CSNK2A3 Q8NEV1 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ ESR1 P03372 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TLR8 Q9NR97 4/20 0.33
▸ TLR7 Q9NYK1 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4793436 0.99 KDM4E (0.35) CSNK2A1PIM1CSNK2A2CSNK2BCSNK2A3
SCHEMBL4794387 0.96 CSNK2A1 (0.35) CSNK2A1PIM1CSNK2A2CSNK2BCSNK2A3
SCHEMBL4790757 0.88 TLR7 (0.44) KDM4EMEN1ALDH1A1ESR1TP53
SCHEMBL6721688 0.87 CSNK2A1 (0.37) CSNK2A1PIM1CSNK2A2CSNK2BCSNK2A3
SCHEMBL4791595 0.87 CSNK2A1 (0.37) CSNK2A1PIM1CSNK2A2CSNK2BCSNK2A3
SCHEMBL4792435 0.87 TLR7 (0.43) KDM4EMEN1ALDH1A1ESR1TP53
SCHEMBL4795712 0.87 TLR7 (0.42) TLR8TLR7
SCHEMBL4793342 0.87 TLR7 (0.47) TLR8TLR7
SCHEMBL4794364 0.86 TLR7 (0.41) TLR8TLR7
SCHEMBL4791472 0.86 TLR7 (0.46) TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7220758-B2 Ether substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-05-22 — — US disclosed
US-20060252792-A1 ETHER SUBSTITUTED IMIDAZOPYRIDINES 3M INNOVATIVE PROPERTIES COMPANY 2006-11-09 — — US disclosed
US-7125890-B2 Ether substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-10-24 — — US disclosed
US-20050032830-A1 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors 3M INNOVATIVE PROPERTIES COMPANY 2005-02-10 — — US disclosed
US-6797718-B2 Ether substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY 2004-09-28 — — US disclosed
US-20040010007-A1 Ether substituted imidazopyridines 3M INNOVATIVE PROPERTIES COMPANY 2004-01-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252792-A1 ETHER SUBSTITUTED IMIDAZOPYRIDINES IL2, IL4, MYD88 CSNK2A1 1611/4885PIM1 275/4885CSNK2A2 2029/4885
US-20050032830-A1 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors IL2, IFNG, TSLP CSNK2A1 1396/4885PIM1 176/4885CSNK2A2 1939/4885
US-20040010007-A1 Ether substituted imidazopyridines IL2, IL4, MYD88 CSNK2A1 1611/4885PIM1 275/4885CSNK2A2 2029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.